The Microdroplet Lift

A patented botulinum toxin delivery method that concentrates treatment along the eyebrows and glabellar area, leaving the forehead untreated, avoids the frozen look that keeps many from having Botox and other neurotoxins. That’s according to the oculoplastic surgeon who patented the Microdroplet Lift, Kenneth Steinsapir, M.D., a clinical associate professor of ophthalmology at the Jules Stein Eye Institute, David Geffen School of Medicine, Los Angeles, Calif. Dr. Steinsapir presented “The Microdroplet Botulinum Toxin Forehead Lift” yesterday at the American Academy of Cosmetic Surgery’s (AACS’s) 2017 annual scientific meeting in San Diego, Calif.
Standard cosmetic botulinum toxin treatments paralyze the forehead, according to Dr. Steinsapir. 
“Consumers do not like their forehead paralyzed,” he says. “That means that 90% of the potential market for this service is afraid to have treatment. The Microdroplet Lift makes it possible to provide a service that relaxes the resting brow pinch, lifts the eyebrows [and] reduces forehead lines without the freeze.”
Read more at Cosmetic Surgery Times >>